Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
Effective, holistic, science-backed targeted solutions for symptomatic treatment
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
The approval further adds to Biocon’s portfolio of complex drug products
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
TABRECTA is the brand of Novartis. Natco believes it is the first company to have filed a substantially-complete ANDA
Subscribe To Our Newsletter & Stay Updated
